Date: 2011-12-22
Type of information:
Compound: EB66® cell line for the production of several animal health vaccine
Company: Vivalis (France) undisclosed animal health company
Therapeutic area: Veterinary medicine
Type agreement: licensing
Action mechanism:
Disease:
Details: Vivalis has signed a research license agreement with an undisclosed major animal health vaccine company granting them the rights to evaluate the EB66® cell line for the production of several animal health vaccine candidates. Terms of the agreement were not disclosed.
Financial terms:
Latest news:
